399 related articles for article (PubMed ID: 32047563)
1. Tumour-Infiltrating Immune Cell-Based Subtyping and Signature Gene Analysis in Breast Cancer Based on Gene Expression Profiles.
Jiang J; Pan W; Xu Y; Ni C; Xue D; Chen Z; Chen W; Huang J
J Cancer; 2020; 11(6):1568-1583. PubMed ID: 32047563
[TBL] [Abstract][Full Text] [Related]
2. The expression profiles of signature genes from CD103
Xia ZA; Lu C; Pan C; Li J; Li J; Mao Y; Sun L; He J
BMC Med; 2023 Jul; 21(1):268. PubMed ID: 37488535
[TBL] [Abstract][Full Text] [Related]
3. Clonality, Antigen Recognition, and Suppression of CD8
Hammerl D; Massink MPG; Smid M; van Deurzen CHM; Meijers-Heijboer HEJ; Waisfisz Q; Debets R; Martens JWM
Clin Cancer Res; 2020 Jan; 26(2):505-517. PubMed ID: 31649042
[TBL] [Abstract][Full Text] [Related]
4. A ferroptosis-associated gene signature for the prediction of prognosis and therapeutic response in luminal-type breast carcinoma.
Peng Y; Yu H; Zhang Y; Qu F; Tang Z; Qu C; Tian J; Zong B; Wang Y; Ren H; Liu S
Sci Rep; 2021 Sep; 11(1):17610. PubMed ID: 34475496
[TBL] [Abstract][Full Text] [Related]
5. M1 Polarization Markers Are Upregulated in Basal-Like Breast Cancer Molecular Subtype and Associated With Favorable Patient Outcome.
Hachim MY; Hachim IY; Talaat IM; Yakout NM; Hamoudi R
Front Immunol; 2020; 11():560074. PubMed ID: 33304345
[TBL] [Abstract][Full Text] [Related]
6. Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in ER (+) and/or PR (+) and HER2 (-) Breast Cancer.
Du F; Zheng F; Han Y; Zhao J; Yuan P
Front Pharmacol; 2022; 13():820437. PubMed ID: 35721151
[No Abstract] [Full Text] [Related]
7. Exploration of the immune-related signature and immune infiltration analysis for breast ductal and lobular carcinoma.
Zhang B; Wang Q; Fu C; Jiang C; Ma S
Ann Transl Med; 2019 Dec; 7(23):730. PubMed ID: 32042746
[TBL] [Abstract][Full Text] [Related]
8. Identification of methylation sites and signature genes with prognostic value for luminal breast cancer.
Xiao B; Chen L; Ke Y; Hang J; Cao L; Zhang R; Zhang W; Liao Y; Gao Y; Chen J; Li L; Hao W; Sun Z; Li L
BMC Cancer; 2018 Apr; 18(1):405. PubMed ID: 29642861
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a prognostic 15-gene signature for stratifying HER2+/ER+ breast cancer.
Liu Q; Huang S; Desautels D; McManus KJ; Murphy L; Hu P
Comput Struct Biotechnol J; 2023; 21():2940-2949. PubMed ID: 37216014
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a glucocorticoid receptor (GR) activity signature correlates with immune cell infiltration in adrenocortical carcinoma.
Wu K; Liu Z; Liang J; Zhu Y; Wang X; Li X
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37793855
[TBL] [Abstract][Full Text] [Related]
11. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of arachidonic acid metabolism in breast cancer by integrated bioinformatics.
Li W; Guo X; Chen C; Li J
Lipids Health Dis; 2022 Oct; 21(1):103. PubMed ID: 36243728
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive research into prognostic and immune signatures of transcription factor family in breast cancer.
Wu Q; Zheng S; Lin N; Xie X
BMC Med Genomics; 2023 Apr; 16(1):87. PubMed ID: 37098532
[TBL] [Abstract][Full Text] [Related]
14. Disparity in Tumor Immune Microenvironment of Breast Cancer and Prognostic Impact: Asian Versus Western Populations.
Chen CH; Lu YS; Cheng AL; Huang CS; Kuo WH; Wang MY; Chao M; Chen IC; Kuo CW; Lu TP; Lin CH
Oncologist; 2020 Jan; 25(1):e16-e23. PubMed ID: 31371522
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive characterization of immune landscape of Indian and Western triple negative breast cancers.
Korlimarla A; Ps H; Prabhu J; Ragulan C; Patil Y; Vp S; Desai K; Mathews A; Appachu S; Diwakar RB; Bs S; Melcher A; Cheang M; Sadanandam A
Transl Oncol; 2022 Nov; 25():101511. PubMed ID: 35964339
[TBL] [Abstract][Full Text] [Related]
16. Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer.
Song C; Shang F; Tu W; Liu X
BMC Cancer; 2023 Mar; 23(1):296. PubMed ID: 37004015
[TBL] [Abstract][Full Text] [Related]
17. Systematic Characterization of Novel Immune Gene Signatures Predicts Prognostic Factors in Hepatocellular Carcinoma.
Xu D; Wang Y; Wu J; Zhang Y; Liu Z; Chen Y; Zheng J
Front Cell Dev Biol; 2021; 9():686664. PubMed ID: 34631695
[No Abstract] [Full Text] [Related]
18. KRAS signaling enriched triple negative breast cancer is associated with favorable tumor immune microenvironment and better survival.
Tokumaru Y; Oshi M; Katsuta E; Yan L; Satyananda V; Matsuhashi N; Futamura M; Akao Y; Yoshida K; Takabe K
Am J Cancer Res; 2020; 10(3):897-907. PubMed ID: 32266098
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic value of tumor infiltration immune cells in pancreatic cancer].
Zhao KL; Liu J; Jiang WN; Hao JH
Zhonghua Wai Ke Za Zhi; 2018 Jun; 56(6):464-470. PubMed ID: 29886672
[No Abstract] [Full Text] [Related]
20. Immune and Stroma Related Genes in Breast Cancer: A Comprehensive Analysis of Tumor Microenvironment Based on the Cancer Genome Atlas (TCGA) Database.
Xu M; Li Y; Li W; Zhao Q; Zhang Q; Le K; Huang Z; Yi P
Front Med (Lausanne); 2020; 7():64. PubMed ID: 32195260
[No Abstract] [Full Text] [Related]
[Next] [New Search]
